References
Evaluation of pDC and mDC activation by LG2055 in vitro. (Flow diagram of this study.pDC activity (CD86 and HLA-DR expression) at 12 weeks. PBMCs obtained from blood samples were stained and analyzed by flow cytometry. CD86 and HLA-DR expression on pDCs were evaluated as pDC activity. Data are shown as mean ± SD (LG2055 group pDC activity (CD86 and HLA-DR expression) at 12 weeks (stratified analysis). PBMCs obtained from blood samples were stained and analyzed by flow cytometry. CD86 and HLA-DR expression on pDCs were evaluated as pDC activity. Participants who showed salivary sIgA secretion rates under the PPS average were selected for the stratified analysis (LG2055 group Nutritional composition of the test samples (per 3 grains).Background characteristics of the participants.Values are presented as mean ± SD. BMI, body mass index.Comparison of the cumulative days of each symptom (two grades).* Significant difference between the two groups (Comparison of the cumulative days on the face scale (two grades).* Significant difference between the two groups (Comparison of the cumulative days of each symptom (two grades) (stratified analysis).* Significant difference between the two groups (Comparison of the cumulative days of face scale (two grades) (stratified analysis).* Significant difference between the two groups (